Alveo Technologies
Announces Partner Program and Portal, New Enablement Software Suite.
Jul 11, 2023
Partnership program advances Alveo’s be.well™ platform accessibility and adoption in new global markets and industry sectors; New partnerships established Alameda, CA – July 11, 2023 – Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and...
Mar 21, 2023
Comprehensive certification process further validates Alveo as a trusted partner in the highly regulated healthcare industry, advances commercialization and partner opportunities globally Alameda, CA – March 21, 2023 – Alveo Technologies, Inc. (Alveo), a leader in...
Feb 9, 2023
Jan 5, 2023
Collaboration supports emergence of Barbados as a life sciences hub in the Caribbean; Accelerates Alveo’s be.well™ platform adoption in new and adjacent markets Alameda, CA – January 5, 2023 – Alveo Technologies, Inc., (Alveo) a leader in molecular sensing and...
Nov 17, 2022
Molecular Sensing and Diagnostics Leader Enters European Market with Novel Point-of-Care Infectious Disease Diagnostic Platform, Seeks Development and Commercialization Partners Alameda, CA – November 17, 2022 – Alveo Technologies, Inc. (Alveo) today announced the...
Mar 16, 2021
Prestigious honor validates potential of Alveo’s low-cost, accessible COVID-19 testing technology as company prepares for commercialization Click to watch how the be.well™ COVID-19 Test works. Alameda, Calif. – March 17, 2021 – Alveo Technologies, Inc. (Alveo)...
Nov 2, 2020
Infectious Disease Diagnostic Innovator Receives Grant from the Bill & Melinda Gates Foundation to Advance Accessibility and Commercialization for At-Home COVID-19 Testing Alameda, CA – 11/2/20 – Alveo Technologies, today announced it has been awarded a grant to...
